Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatment
- 1 June 1987
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 41 (6) , 597-602
- https://doi.org/10.1038/clpt.1987.81
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.British Journal of Clinical Pharmacology, 1986
- Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.British Journal of Clinical Pharmacology, 1986
- Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.BMJ, 1982
- Enalapril maleate and a lysine analogue (MK‐521): disposition in man.British Journal of Clinical Pharmacology, 1982
- THE PHYSIOLOGICAL DISPOSITION AND METABOLISM OF ENALAPRIL MALEATE IN LABORATORY-ANIMALS1982
- A liquid chromatography-assisted assay for angiotensin-converting enzyme (peptidyl dipeptidase) in serum.Clinical Chemistry, 1979